Difference between revisions of "LP:Sandbox"

From Libre Pathology
Jump to: navigation, search
(Test 1)
(Test 2)
Line 80: Line 80:
 
</tr>
 
</tr>
 
</table>
 
</table>
 +
 +
==Test 3==
 +
<table><tr>
 +
<th>
 +
 +
<table class="wikitable mw-collapsible mw-collapsed"><tr><th>Translocations Chr 14-22</th></tr><tr><th><table class="wikitable sortable"><tr><th>Test</th> <th>Result</th></tr>
 +
<tr><td>JAK2 V617F  ARMS </td><td class="mw-collapsible mw-collapsed">{{#if:{{{jak2_v617f| }}} | {{{jak2_v617f}}} | {{{blank}}}  }}</td></tr>
 +
<tr><td>EBV PCR </td><td class="mw-collapsible mw-collapsed">{{#if:{{{EBV_pcr| }}} | {{{EBV_pcr}}} | {{{blank}}}  }}</td></tr>
 +
<tr><td>HHV-8 PCR </td><td class="mw-collapsible mw-collapsed">{{#if:{{{hhv8_pcr| }}} | {{{hhv8_pcr}}} | {{{blank}}}  }}</td></tr>
 +
</table></th></tr></table></th>
 +
 +
</tr></table>
  
 
==See also==
 
==See also==

Revision as of 10:25, 19 September 2015

Atypical granulocytic lineage cells in a patient with myelodysplasia.
Atypical ductal hyperplasia. Very low magnification. H&E stain. (WC/Nephron)

The sandbox is a test page.

This is a place where things can be tried.

A reference follows this sentence.[1]

Another references follows this sentence.[2]

Section

This is another section.

Tubular adenomas are a precursor CRC[3] Example.jpg

A brokennn link is here.

File:Link to nonexistant file.jpg

DOI

doi:10.1038/ng.2868

doi:10.1038/ng.2868

Test 1

Translocations Chr 1-10
Test Result
t(1;13) PAX7-FKHR {{{blank}}}
t(2,13) PAX3-FKHR {{{blank}}}
t(8;14) MYC-IGH{{{blank}}}
t(9;22) BCR-ABL {{{blank}}}
t(9;22) CHN-EWS {{{blank}}}
Translocations Chr 11-13
Test Result
t(11;14) CCND1-IGH {{{blank}}}
t(11;22) EWS-WT1 {{{blank}}}
t(11;22) FLI1-EWS {{{blank}}}
t(12;15) ETV6-NTRK3 {{{blank}}}
t(12;16) FUS-ATF1 {{{blank}}}
t(12;16) CHOP-TLS {{{blank}}}
t(12;22) EWS-ATF1 {{{blank}}}
Translocations Chr 14-22
Test Result
t(14,18) IGH-BCL2 {{{blank}}}
t(15;17) PML-RARA {{{blank}}}
t(16;21) FUS-ERG {{{blank}}}
t(17;22) COLA1-PDGFB {{{blank}}}
t(21;22) EWS-ERG {{{blank}}}
Translocations Chr X & Y
Test Result
t(X;1) PRCC-TFE3{{{blank}}}
t(X;17) TFE3-ASPL {{{blank}}}
t(X;18) SYT-SSX {{{blank}}}


Test 2

Translocations Chr 1-10
Test Result
t(1;13) PAX7-FKHR {{{blank}}}
t(2,13) PAX3-FKHR {{{blank}}}
t(8;14) MYC-IGH{{{blank}}}
t(9;22) BCR-ABL {{{blank}}}
t(9;22) CHN-EWS {{{blank}}}
Translocations Chr X & Y
Test Result
t(X;1) PRCC-TFE3{{{blank}}}
t(X;17) TFE3-ASPL {{{blank}}}
t(X;18) SYT-SSX {{{blank}}}

Test 3

Translocations Chr 14-22
Test Result
JAK2 V617F ARMS {{{blank}}}
EBV PCR {{{blank}}}
HHV-8 PCR {{{blank}}}

See also

References

  1. This is a reference.
  2. Bonert, M.; Saville, BA. (2010). "A non-dimensional analysis of hemodialysis.". Open Biomed Eng J 4: 138-55. doi:10.2174/1874120701004010138. PMID 21673980.
  3. Roloff, KA.; Brown, E.; Stepanyan, G.; Valenzuela, GR. (May 2015). "Timing of Indicated Repeat Cesarean Delivery Before 39 Weeks of Gestation [151].". Obstet Gynecol 125 Suppl 1: 52S. doi:10.1097/01.AOG.0000463691.56327.ae. PMID 25930481.